2,6-diaminopurine has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adriaenssens, E; Amand, S; Bailly, C; Benhabiles, H; Chassat, T; Copin, MC; Duvernois-Berthet, E; Guilbert, R; Hannebique, D; Kulozik, A; Lejeune, F; Leroy, C; Marchand, V; Moreau, PA; Motorin, Y; Mouray, A; Rebuffat, S; Saliou, JM; Trzaska, C; Tulasne, D; Werkmeister, E; Westhof, E | 1 |
1 other study(ies) available for 2,6-diaminopurine and Disease Models, Animal
Article | Year |
---|---|
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations.
Topics: 2-Aminopurine; Animals; Codon, Nonsense; Disease Models, Animal; Drug Discovery; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genes, p53; HEK293 Cells; HeLa Cells; Humans; Lepisma; Mice; Mice, Nude; Mutation; RNA, Transfer; tRNA Methyltransferases | 2020 |